Table:1Impact Analysis of Market Dynamics
Table:2Price Analysis
Table:3Competitor Mapping & Benchmarking
Table:4Japan Pet Cancer Therapeutics Market Size (US$ Mn), By Therapy, 2018-2031
Table:5Japan Pet Cancer Therapeutics Market Size (US$ Mn), By Route of Administration, 2018-2031
Table:6Japan Pet Cancer Therapeutics Market Size (US$ Mn), By Species, 2018-2031
Table:7Japan Pet Cancer Therapeutics Market Size (US$ Mn), By Application, 2018-2031
Table:8Japan Pet Cancer Therapeutics Market Size (US$ Mn), By Distribution Channel, 2018-2031
Table:9Boehringer Ingelheim International GmbH: Recent Developments
Table:10Boehringer Ingelheim International GmbH: Products Features
Table:11Boehringer Ingelheim International GmbH: Financial Analysis
Table:12Zoetis Inc.: Recent Developments
Table:13Zoetis Inc.: Products Features
Table:14Zoetis Inc.: Financial Analysis
Table:15AB Science: Products Features
Table:16AB Science: Financial Analysis
Table:17Elanco Animal Health Incorporated: Recent Developments
Table:18Elanco Animal Health Incorporated: Products Features
Table:19Elanco Animal Health Incorporated: Financial Analysis
Table:20ELIAS Animal Health LLC: Recent Developments
Table:21ELIAS Animal Health LLC: Products Features
Table:22Karyopharm Therapeutics Inc.: Products Features
Table:23Karyopharm Therapeutics Inc.: Financial Analysis
Table:24Regeneus Ltd.: Products Features
Table:25Regeneus Ltd.: Financial Analysis
Table:26Rhizen Pharmaceuticals AG: Product Features
Table:27Pfizer Inc.: Recent Developments
Table:28Pfizer Inc.: Products Features
Table:29Pfizer Inc.: Financial Analysis
Table:30Torigen Pharmaceuticals Inc.: Recent Developments
Table:31Torigen Pharmaceuticals Inc.: Products Features
Table:32Virbac: Recent Developments
Table:33Virbac: Products Features
Table:34Virbac: Financial Analysis
Table:35Sumitomo Pharma Animal Health Co.: Products Features
Table:36Nippon Zenyaku Kogyo Co., Ltd.: Products Features
Figure:1Japan Pet Cancer Therapeutics Market, Revenue (US$ Mn), 2018-2031
Figure:2Value Chain Overview of the Japan Pet Cancer Therapeutics Market
Figure:3Value Chain Overview of the Japan Pet Cancer Therapeutics Market
Figure:4Top ten disease related cause of death in dogs
Figure:5Top ten disease related cause of death in cats
Figure:6Adoption Rate (%), By Therapy
Figure:7Japan Pet Cancer Therapeutics Market, by Y-o-Y (%), 2019 – 2031
Figure:8Revenue Comparison, By Route of Administration (US$ Mn), 2021, 2026, 2031
Figure:9Spending on Pets, By Expenses, 2021
Figure:10Japan Pet Cancer Therapeutics Market, Covid-19 Impact & Recovery, By YoY (%), 2019-2031
Figure:11Market Concentration Rate (2022)
Figure:12Japan Market Share Analysis, By Company, 2022
Figure:13Japan Market Share Analysis, By Company, 2027
Figure:14Japan Market Share Analysis, By Company, 2031
Figure:15Japan Pet Cancer Therapeutics Market, By Therapy, CAGR (%), 2023-2031
Figure:16Japan Pet Cancer Therapeutics Market Share (%), By Therapy, 2022
Figure:17Japan Pet Cancer Therapeutics Market Share (%), By Therapy, 2031
Figure:18Japan Pet Cancer Therapeutics Market, By Route of Administration, CAGR (%), 2023-2031
Figure:19Japan Pet Cancer Therapeutics Market Share (%), By Route of Administration, 2022
Figure:20Japan Pet Cancer Therapeutics Market Share (%), By Route of Administration, 2031
Figure:21Japan Pet Cancer Therapeutics Market, By Species, CAGR (%), 2023-2031
Figure:22Japan Pet Cancer Therapeutics Market Share (%), By Species, 2022
Figure:23Japan Pet Cancer Therapeutics Market Share (%), By Species, 2031
Figure:24Japan Pet Cancer Therapeutics Market, By Application, CAGR (%), 2023-2031
Figure:25Japan Pet Cancer Therapeutics Market Share (%), By Application, 2022
Figure:26Japan Pet Cancer Therapeutics Market Share (%), By Application, 2031
Figure:27Japan Pet Cancer Therapeutics Market, By Distribution Channel, CAGR (%), 2023-2031
Figure:28Japan Pet Cancer Therapeutics Market Share (%), By Distribution Channel, 2022
Figure:29Japan Pet Cancer Therapeutics Market Share (%), By Distribution Channel, 2031
Figure:30Boehringer Ingelheim International GmbH: Business Revenue Segmentation, 2021
Figure:31Boehringer Ingelheim International GmbH: Geographical Revenue Segmentation, 2021
Figure:32Zoetis Inc.: Business Revenue Segmentation, 2021
Figure:33Zoetis Inc.: Geographical Revenue Segmentation, 2021
Figure:34Elanco Animal Health Incorporated: Business Revenue Segmentation, 2021
Figure:35Elanco Animal Health Incorporated: Geographical Revenue Segmentation, 2021
Figure:36Karyopharm Therapeutics Inc.: Business Revenue Segmentation, 2021
Figure:37Pfizer Inc.: Business Revenue Segmentation, 2021
Figure:38Pfizer Inc.: Geographical Revenue Segmentation, 2021
Figure:39Virbac: Business Revenue Segmentation, 2021
| レポートID: AA0123018 